ECCX Q1 2026 Earnings EPS Misses Estimates Slightly Notes Decline Marginally TRNR Q4 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues Nexxen International Q3 2025 Earnings Strong EPS Surprise Amplifies Confidence in Profitability Velocity Financial Q1 2026 Earnings EPS Surpasses Estimates with 52 Beat Embecta Corp EMBC Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed